Edition:
United States

KPC Pharmaceuticals Inc (600422.SS)

600422.SS on Shanghai Stock Exchange

9.61CNY
15 Dec 2017
Change (% chg)

¥0.36 (+3.89%)
Prev Close
¥9.25
Open
¥9.34
Day's High
¥9.87
Day's Low
¥9.34
Volume
13,624,466
Avg. Vol
7,204,799
52-wk High
¥13.76
52-wk Low
¥8.96

Summary

Name Age Since Current Position

Xiaochang Dai

52 2015 President

C.H. Lin

47 2009 Vice Chairman of the Board

Shaoquan Wang

45 2009 Chief Financial Officer

Chaoneng Xu

49 Vice President, Secretary of the Board

Zhongzhan Lin

44 2010 Vice President

Peng Liu

49 2012 Vice President

Rong Pei

42 Director

Siyang Wang

26 Director

Wanshou Li

50 2013 Independent Director

Jian Mei

46 2009 Independent Director

Pengfei Tu

50 2012 Independent Director

Jinguo Xin

50 2009 Independent Director

Biographies

Name Description

Xiaochang Dai

C.H. Lin

Mr. Lin Jiahong has been Vice Chairman of the Board in Kunming Pharmaceutical Corp. since November 2009. He was Director in the Company. He is also General Manager-Asset Operation in a Yunnan-based industry investment company. He used to serve as Chairman of the Board in a Yunnan-based energy conservation investment company.

Shaoquan Wang

Mr. Wang Shaoquan has been Chief Financial Officer in Kunming Pharmaceutical Corp. since November 2009. He was Assistant to Chief Financial Officer in the Company. He used to be Chief Financial Officer in a Beijing-based medicine company, as well as Director in a Wuhan Jianmin Pharmaceutical Group Co., Ltd.

Chaoneng Xu

Mr. Xu Chaoneng is Vice President and Secretary of the Board in Kunming Pharmaceutical Corp. He was Chief Financial Officer in the Company.

Zhongzhan Lin

Mr. Lin Zhongzhan has been Vice President in Kunming Pharmaceutical Corp. since December 24, 2010. He was Assistant to the President, Chief Sales Officer, General Manager-Kunnan Branch, Acting General Manager-Marketing Center and Deputy General Manager in the Company. He used to be Executive Deputy General Manager in a Kunming-based medicine sales company, as well as Chief Sales Officer in a Wuhan-based pharmaceutical group company.

Peng Liu

Mr. Liu Peng has been serving as Vice President in Kunming Pharmaceutical Corp. since August 13, 2012. He used to serve as Vice President in Wuhan Jianmin Pharmaceutical Group Co., Ltd.

Rong Pei

Ms. Pei Rong is Director in Kunming Pharmaceutical Corp. She is also Chief Financial Officer and Chief Operation Officer in a group, as well as Director in a medicine technology company and a Wuhan-based pharmaceutical group. She used to be Chief Financial Officer in a group.

Siyang Wang

Mr. Wang Siyang is Director in Kunming Pharmaceutical Corp. He is also Assistant President in a group company, as well as Director in Wuhan Jianmin Pharmaceutical Group Co., Ltd.

Wanshou Li

Jian Mei

Mr. Mei Jian has been Independent Director in Kunming Pharmaceutical Corp. since November 2009. He used to be Manager of Investment, Senior Manager of Investment and General Manager-Asset Operation Headquarter in Shenzhen Capital Group Co., Ltd.

Pengfei Tu

Mr. Tu Pengfei is Independent Director of Kunming Pharmaceutical Corp. He is also Independent Director of Wuhan Jianmin Pharmaceutical Group Co., Ltd. He is Professor in Peking University, China.

Jinguo Xin

Mr. Xin Jinguo has been Independent Director in Kunming Pharmaceutical Corp. since November 2009. He is Professor of Accountant. He holds a Ph.D. in Management. He is Certified Public Accountant.

Basic Compensation

Name Fiscal Year Total

Xiaochang Dai

--

C.H. Lin

135,000

Shaoquan Wang

450,000

Chaoneng Xu

350,000

Zhongzhan Lin

450,000

Peng Liu

225,000

Rong Pei

90,000

Siyang Wang

90,000

Wanshou Li

--

Jian Mei

90,000

Pengfei Tu

15,000

Jinguo Xin

90,000
As Of  30 Dec 2012